Aytu Biopharma (AYTU) Long-Term Debt Repayments (2011 - 2026)
Aytu Biopharma's Long-Term Debt Repayments came in at $464,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), unchanged from $464,000 a year earlier and unchanged from the prior quarter.
Aytu Biopharma (AYTU) Long-Term Debt Repayments (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Long-Term Debt Repayments was $1.86 million, unchanged from FY2025.
- Long-Term Debt Repayments carries a five-year compound annual growth rate of 13.9% (FY2021 to FY2026).
- Going back by fiscal year, Long-Term Debt Repayments was $1.86 million in FY2025 (-88.2%), $15.72 million in FY2024, $96,000 in FY2023 (-99.4%) and $16.1 million in FY2022.
- The five-year range for quarterly Long-Term Debt Repayments is -$73.56 million (fiscal Q3 2022) to $89.61 million (fiscal Q2 2022).
- The fastest year-over-year change in Long-Term Debt Repayments over five years came in fiscal Q1 2023 (growth of 4.0%), and the weakest in fiscal Q4 2025 (a decline of 97.0%).
- Business Quant data shows AYTU's Long-Term Debt Repayments at $464,000 (Q3 2026), $465,000 (Q2 2026) and $464,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Aytu Biopharma | 24.31 Mn | -91.36 Mn | 10.41 Mn | 464,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 464,000.00 |
| Mar 31, 2026 | 464,000.00 |
| Dec 31, 2025 | 465,000.00 |
| Sep 30, 2025 | 464,000.00 |
| Jun 30, 2025 | 464,000.00 |
| Mar 31, 2025 | 464,000.00 |
| Dec 31, 2024 | 465,000.00 |
| Sep 30, 2024 | 464,000.00 |
| Jun 30, 2024 | 15.65 Mn |
| Mar 31, 2024 | 25,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 73,000.00 |
| Dec 31, 2022 | -26,000.00 |
| Sep 30, 2022 | 26,000.00 |
| Jun 30, 2022 | 26,000.00 |
| Mar 31, 2022 | -73.56 Mn |
| Dec 31, 2021 | 89.61 Mn |
| Sep 30, 2021 | 25,000.00 |
Aytu Biopharma Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AYTU&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();